Prudential Financial’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Prudential Financial’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,097	Closed	-$236K	–	2364
2017 Q3	$236K	Sell	2,097 -309	-13%	-$33.6K	﹤0.01%	2219
2017 Q2	$269K	Sell	2,406 -920	-28%	-$104K	﹤0.01%	2178
2017 Q1	$388K	Sell	3,326 -211	-6%	-$23.4K	﹤0.01%	2092
2016 Q4	$373K	Sell	3,537 -3,347	-49%	-$351K	﹤0.01%	2101
2016 Q3	$761K	Buy	6,884 +490	+8%	+$64.9K	﹤0.01%	1894
2016 Q2	$931K	Buy	6,394 +730	+13%	+$104K	﹤0.01%	1853
2016 Q1	$811K	Buy	+5,664	New	+$805K	﹤0.01%	1879

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Prudential Financial's TARO Position: Q4 2017 in Review

Prudential Financial sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 2,097 shares — an estimated $236K sold.

Prudential Financial first reported a position in TARO in Q1 2016 and held it in 7 quarters. The position peaked at $931K in Q2 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

Prudential Financial reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
Prudential Financial sold 2,097 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $236K.
Prudential Financial first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 7 quarters.
Prudential Financial's Taro Pharmaceutical Industries Ltd. position peaked at $931K in Q2 2016.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Prudential Financial's 13F filing for Q4 2017, filed 13 Feb 2018.